SYTL1
Synaptotagmin-like protein 1
Also known as: exophilin-7, FLJ14996, JFC1, SLP1, SYTL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYJ3
- Gene
- SYTL1
- Ensembl
- ENSG00000142765
- Chromosome
- 1
- Canonical length
- 562 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable neurexin family protein binding activity. Involved in exocytosis. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
562 residues, UniProt reviewed canonical sequence.
>Q8IYJ3|SYTL1
1 MPQRGHPSQE GLWALPSLPM AHGPKPETEG LLDLSFLTEE EQEAIAGVLQ RDARLRQLEE
61 GRVSKLRASV ADPGQLKILT GDWFQEARSQ RHHNAHFGSD LVRASMRRKK STRGDQAPGH
121 DREAEAAVKE KEEGPEPRLT IDEAPQERLR ETEGPDFPSP SVPLKASDPE EASQAQEDPG
181 QGDQQVCAEE ADPELEPASG GEQEPRPQQA QTKAASQILE NGEEAPGPDP SLDRMLSSSS
241 SVSSLNSSTL SGSQMSLSGD AEAVQVRGSV HFALHYEPGA AELRVHVIQC QGLAAARRRR
301 SDPYVKSYLL PDKQSKRKTA VKKRNLNPVF NETLRYSVPQ AELQGRVLSL SVWHRESLGR
361 NIFLGEVEVP LDTWDWGSEP TWLPLQPRVP PSPDDLPSRG LLALSLKYVP AGSEGAGLPP
421 SGELHFWVKE ARDLLPLRAG SLDTYVQCFV LPDDSQASRQ RTRVVRRSLS PVFNHTMVYD
481 GFGPADLRQA CAELSLWDHG ALANRQLGGT RLSLGTGSSY GLQVPWMDST PEEKQLWQAL
541 LEQPCEWVDG LLPLRTNLAP RTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYTL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 101 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 101 nTPM
- esophagus: 99 nTPM
- skin: 83 nTPM
- prostate: 62 nTPM
- vagina: 48 nTPM
- salivary gland: 46 nTPM
Single-cell type
- esophageal apical cells: 375 nCPM
- esophageal suprabasal cells: 327 nCPM
- esophageal basal cells: 223 nCPM
- prostatic hillock cells: 144 nCPM
- suprabasal keratinocytes: 135 nCPM
- respiratory basal cells: 127 nCPM
Immune cell
- eosinophil: 177 nTPM
- non-classical monocyte: 101 nTPM
- gdT-cell: 65 nTPM
- T-reg: 64 nTPM
- MAIT T-cell: 59 nTPM
- memory CD8 T-cell: 53 nTPM
Brain region
- cerebellum: 18 nTPM
- choroid plexus: 13 nTPM
- amygdala: 8.4 nTPM
- hypothalamus: 2.7 nTPM
- cerebral cortex: 2.6 nTPM
- hippocampal formation: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.3
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SYTL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYTL1 as an antibody target. Whether an autoantibody or antibody against SYTL1 could matter depends on whether native SYTL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYTL1 is annotated at the cell surface, where native SYTL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SYTL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...